The biology of hairy cells

Best Practice and Research: Clinical Haematology

Volumn 16, Issue 1, 2003, Pages 1-13

  Zuzel, M ^a   Cawley, J C ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adhesion receptors; B cells; Cell activation; Cell signalling; Cytogenetics; Cytokines; Fibrosis; Hairy cells; Hairy cell leukaemia; Homing; IFN ; Pseudosinuses; Surface immunoglobulin; T cells

Indexed keywords

ALPHA INTERFERON; ALPHA4 INTEGRIN; B LYMPHOCYTE RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; CD103 ANTIGEN; CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; CYCLIN D1; CYTOKINE; FIBRINOGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HERMES ANTIGEN; INTERLEUKIN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NUCLEOSIDE ANALOG; PROTEIN BCL 6; PROTEIN P53; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; ANTIGEN; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CELL STRUCTURE; CELL TYPE; CHROMOSOME ABERRATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DRUG SENSITIVITY; GENETIC DISORDER; HAIRY CELL LEUKEMIA; HUMAN; LEUKEMIA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; B LYMPHOCYTE; BIOLOGY; CANCER CELL; CELL ACTIVATION; CYTOKINE RELEASE; DENDRITIC CELL; GENE MUTATION; LEUKOPENIA; MONOCYTE; PANCYTOPENIA; T LYMPHOCYTE;

EID: 0037251725     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6926(02)00082-8     Document Type: Review

References (50)

1. Burthem J & Cawley JC. Hairy-Cell Leukaemia. Berlin: Springer-Verlag, 1996.
2. Bouroncle BA, Wiseman BK & Doan CA. Leukemic reticuloendotheliosis. Blood 1958; 13: 609-630.
3. Burns GF, Cawley JC, Worman CP et al. Multiple heavy chain isotypes on the surface of the cells of hairy-cell leukemia. Blood 1978; 52: 1132-1147.
4. Kluin-Nelemans HC, Krouwels MM, Jansen JH et al. Hairy-cell leukaemia preferentially expresses the IgG3-subclass. Blood 1990; 7S: 972-975.
5. Forconi F, Sahota SS, Raspadori D et al. Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. Blood 2001; 98: 1174-1181.
6. Maloum K, Magnac C, Azgui Z et al. VH gene expression in hairy cell leukaemia. British Journal of Haematology 1998; 101: 171-178.
7. Welleer S, Faili A, Garcia C et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proceedings of the National Academy of Sciences of the USA 2001; 98: 1166-1170.
8. Pettitt AR, Zuzel M & Cawley JC. Hairy-cell leukaemia: biology and management. British Journal of Haematology 1999; 106: 2-8.
9. Sambani C, Trafalis DT, Mitsoulis-Mentzikoff C et al. Clonal chromosome rearrangements in hairy cell leukaemia: personal experience and review of literature. Cancer Genetics and Cytogenetics 2001; 129: 138-144.
10. Wu X, Ivanova G, Merup M et al. Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates. Genomics 1999; 60: 161-171.
11. Vallianatou K, Brito-Babapulle V, Matutes E et al. p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant. Leukemia Research 1999; 23: 1041-1045.
12. Konig EA, Kusser WC, Day C et al. p53 mutations in hairy cell leukemia. Leukemia 2000; 14: 706-711.
13. Capella D, Vitolo U, Pasqualucci L et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000; 95: 651-659.
14. Brito-Babapulle V, Matutes E & Catovsky D. Cytogenetics, molecular genetics and immunophenotyping in hairy cell leukemia. In Tallman MS & Polliack A (eds) Hairy Cell Leukemia, pp 51-52. Amsterdam: Harwood, 2000.
15. Katayama I, Li CY & Yam LT. Ultrastructural characteristics of the 'hairy cells' of leukemia reticuloendotheliosis. American Journal of Pathology 1972; 67: 361-370.
16. Caligaris-Cappio FG, Bergui L, Corbascio G et al. Cytoskeletal organisation is aberrantly rearranged in the cells of B chronic lymphocytic leukemia. Blood 1986; 67: 233-239.
17. Yam LT, Li CY & Lam KW. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. New England Journal of Medicine 1971; 284: 357-360.
18. Caligaris-Cappio F, Pizzolo G, Chilosi M et al. Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood 1985; 66: 1035-1042.
19. Burthem J, Zuzel M & Cawley JC. What is the nature of the hairy cell and why should we be interested? British Journal of Haematology 1997; 97: 511-514.
20. van Der Vuurst De Vries AR & Logtenberg T. A phage antibody identifying an 80-kDa membrane glycoprotein exclusively expressed an a subpopulation of activated B cells and hairy cell leukemia B cells. European Journal of Immunology 1999; 29: 3898-3907.
21. Baker PK, Pettitt AR, Slupsky JR et al. Response of hairy cells to IFNα involves induction of apoptosis through autocrine TNF-α and protection by adhesion. Blood 2002; 100: 647-653.
22. Burthem J, Baker PK, Hunt JA & Cawley JC. Hairy cell interactions with extracellular matrix; expression of specific integrin receptors and their role in the cell's response to specific adhesive proteins. Blood 1994; 84: 873-882.
23. Aziz KA, Till KJ, Zuzel M & Cawley JC. Involvement of CD44-hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia. Blood 2000; 96: 3161-3167.
24. Burthem J & Cawley JC. The bone marrow fibrosis of hairy cell leukemia is caused by the synthesis and assembly of a fibronectin matrix by hairy cells. Blood 1994; 83: 497-504.
25. Barak V, Nisman B, Polliack A et al. Correlation of serum levels of interleukin-I family members with disease activity and response to treatment in hairy cell leukaemia. European Cytokine Network 1998; 9: 33-39.
26. Takeuchi H & Katayama I. Interleukin-I (IL-I alpha and IL-I beta) induces the differentiation/activation of B-cell chronic lymphoid leukaemia cells. Cytokine 1994; 6: 243-246.
27. Semenzato G, Trentin L, Zambello R et al. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia. Leukemia 1988; 2: 788-792.
28. Barut BA, Cochran MK, O'Hara C & Anderson KC. Response patterns of hairy cell leukemia to B cell mitogens and growth factors. Blood 1990; 76: 2091-2097.
29. Munoz L, Nomdedeu JF, Lopez O et al. Interleukin-3 receptor αchain (CD 123) is widely expressed in haematological malignancies. Haematologica 2001; 86: 1261-1269.
30. Heslop HE, Bianchi AC, Cordingley FT et al. Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders. Journal of Experimental Medicine 1990; 172: 1729-1734.
31. Barak V, Nisman B & Foa R. Cytokines and cytokine receptors in hairy cell leukaemia: clinical relevance and correlation with disease activity. In Tallman MS & Polliack A (eds) Hairy Cell Leukemia, p 121. Amsterdam: Harwood, 2000.
32. Kluin-Nelemans HC, Kester MG, Oving I et al. Abnormally activated T lymphocytes in the spleen of patients with hairy-cell leukemia. Leukemia 1994; 8: 2095 -2101.
33. Trentin L, Zambello R, Facco M et al. Interleukin 16: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leukemia & Lymphoma 1997; 27: 35-42.
34. Till KJ, Burthem J, Lopez A & Cawley JC. GM-CSF receptor: stage specific expression and function on late B cells. Blood 1996; 88: 479-486.
35. Burthem J, Baker PK, Hunt JA & Cawley JC. The action of M-CSF on B cells: M-CSF stimulates HC movement. Blood 1994; 83: 1381-1389.
36. Gruber G, Schwarzmeier JD, Shehata M et al. Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia. Blood 1999; 94: 1077-1085.
37. Shehata M, Scwarzmeier JD, Nguyen ST et al. Reconstitution of endogenous interferon-α by recombinant interferon in hairy cell leukemia. Cancer Research 2000; 60: 5420-5426.
38. Genot EM, Meier KE, Licciardi KA et al. Phosphorylation of CD20 in cells from a hairy cell leukemia cell line. Evidence for involvement of calcium/calmodulin-dependent protein kinase II. Journal of Immunology 1993; 151: 71-82.
39. Lynch SA, Brugge JS, Fromowitz F et al. Increased expression of the src proto-oncogene in hairy cell leukemia and a subgroup of B-cell lymphomas. Leukemia 1993; 7: 1416-1422.
40. Lower EE, Franco RS & Martelo OJ. Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias. American Journal of Medical Sciences 1992; 303: 387-391.
41. Seshadri RS, Brown EJ & Zipursky A. Leukemic reticuloendotheliosis: a failure of monocytic production. New England Journal of Medicine 1976; 295: 181-184.
42. Bourguin-Plonquet A, Rouard H, Roudot-Thoraval F et al. Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia. British Journal of Haematology 2002; 116: 595-597.
43. +) in hairy cell leukemia. Leukemia 1993; 7: 46-50.
44. Trentin L, Zambello R, Agostini C et al. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood 1990; 75: 1525-1530.
45. van de Corput L, Falkenburg JH, Kester MG et al. Impaired expression of CD28 on T cells in hairy cell leukemia. Clinical Immunology 1999; 93: 256-262.
46. Kluin-Nelemans HC, Kester MG, Melenhorst JJ et al. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996; 87: 3795-3802.
47. Cawley JC, Zuzel M & Caligaris-Cappio F. Biology of the Hairy Cell. In Tallman MS & Polliack A (eds) Hairy Cell Leukemia, p 14. Amsterdam: Harwood, 2000.
48. 1 in the unusual tissue distribution of hairy cell leukemia. Blood 1996; 88: 3945-3952.
49. Trentin L, Agostini C, Facco M et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. Journal of Clinical Investigation 1999; 104: 115-121.
50. Durig J, Schmucker U & Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 2001; 15: 752-756.